Database : MEDLINE
Search on : Conjunctivitis [Words]
References found : 12881 [refine]
Displaying: 1 .. 10   in format [Detailed]

page 1 of 1289 go to page                         

  1 / 12881 MEDLINE  
              next record last record
select
to print
Photocopy
PubMed Central Full text
Full text

[PMID]: 25077156
[Au] Autor:Ghaemi S; Navaei P; Rahimirad S; Behjati M; Kelishadi R
[Ad] Address:Departments of Pediatrics, Child Growth and Development Research Center, and Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran....
[Ti] Title:Evaluation of preventive effects of colostrum against neonatal conjunctivitis: A randomized clinical trial.
[So] Source:J Educ Health Promot;3:63, 2014.
[Is] ISSN:2277-9531
[Cp] Country of publication:India
[La] Language:eng
[Ab] Abstract:BACKGROUND: Neonatal conjunctivitis leads to several ocular consequences in the affected neonates such as blindness. Currently available therapeutic options include NaNO3, Gentamicin, Neomycin and so on, in which each of them has their own limitations. Regarding the immunologic content of colostrum and its safety and easy accessibility, we aimed to evaluate its preventive effects against neonatal conjunctivitis. MATERIALS AND METHODS: In this clinical trial, conducted from November 2011 to July 2012, 300 preterm neonates, with culture negative eye swab, were enrolled and randomly assigned into three groups. The intervention group received two drops of colostrum. Control group received no treatment and other neonates were treated with topical Erythromycin ointment (0.5%). All neonates were followed for occurrence of clinical conjunctivitis for 28 days. Data analysis were performed by Chi-square test. RESULTS: Our data demonstrate the beneficial preventive effects of Colostrum against neonatal conjunctivitis (P = 0.036). CONCLUSION: Colostrum is suggested as an alternative prophylactic option for antibiotics against neonatal conjunctivitis. As colostrum is easily accessible without cost, potential hazards and side effects, public education about its topical favorable effects is worthwhile.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1407
[Cu] Class update date: 140804
[Lr] Last revision date:140804
[Da] Date of entry for processing:140731
[St] Status:PubMed-not-MEDLINE
[do] DOI:10.4103/2277-9531.134776

  2 / 12881 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
PubMed Central Full text
Full text

[PMID]: 24695688
[Au] Autor:Fukushima A; Ohashi Y; Ebihara N; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Namba K; Fujishima H; Miyazaki D
[Ad] Address:Department of Ophthalmology, Kochi Medical School, Kochi, Japan....
[Ti] Title:Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement.
[So] Source:Br J Ophthalmol;98(8):1023-7, 2014 Aug.
[Is] ISSN:1468-2079
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:BACKGROUND: The objective of this study was to investigate the efficacy of topical 0.1% tacrolimus in treating refractory allergic conjunctivitis with proliferative lesions and/or corneal involvement. METHODS: This prospective observational study included 1436 patients with refractory allergic conjunctivitis whose condition had responded poorly to conventional antiallergic drugs and/or topical steroids and/or topical cyclosporine. All patients received tacrolimus eye drops twice daily during the study period. Ten clinical signs and six clinical symptoms were rated on a four-grade scale. The primary endpoint was the change from baseline in total clinical signs and symptoms score at the last observation or following 6 months of treatment. RESULTS: Total signs and symptoms score significantly decreased after 1 month of treatment (p<0.001). Giant papillae and corneal lesions were also reduced by tacrolimus eye drop use (p<0.001). The drug proved effective in patients whose condition did not respond well to topical cyclosporine therapy. About 50% of all patients using topical steroids were weaned. The most common adverse reaction was a transient burning sensation (3.20%). CONCLUSIONS: Tacrolimus eye drops are highly effective in treating refractory allergic conjunctivitis with proliferative lesions and/or corneal involvement, and may reduce or replace topical steroid use. TRIAL REGISTRATION NUMBER: UMIN 000008640.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1407
[Js] Journal subset:IM
[St] Status:In-Data-Review
[do] DOI:10.1136/bjophthalmol-2013-304453

  3 / 12881 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy

[PMID]: 24955802
[Au] Autor:Sulis G; Urbinati L; Franzoni A; Gargiulo F; Carvalho AC; Matteelli A
[Ad] Address:University Division of Infectious and Tropical Diseases; Eye Clinic, Department of Neurological Sciences and Vision, University of Brescia; Laboratory of Microbiology, Spedali Civili General Hospital, Brescia, Italy; Laboratory of Innovations in Therapies, Education and Bioproducts (LITEB), Oswaldo ...
[Ti] Title:Chlamydia trachomatis conjunctivitis in a male teenager: a case report.
[So] Source:Infez Med;22(2):140-3, 2014 Jun.
[Is] ISSN:1124-9390
[Cp] Country of publication:Italy
[La] Language:eng
[Ab] Abstract:An 18 year old man was seen at a Sexually Transmitted Infections (STIs) clinic for counselling and treatment of Chlamydia trachomatis genital infection which had been diagnosed during a screening survey of high school students. For two months he had reported conjunctival hyperaemia, increased tearing, itching, and mucopurulent secretions, predominantly on the left eye. His ophthalmologist had made a diagnosis of follicular conjunctivitis and lower superficial punctate keratitis (left eye more than right eye), irresponsive to topical treatment. Chlamydial conjunctivitis was suspected and confirmed by a positive nucleic acid amplification test (NAAT) performed on conjunctival scraping. The patient was treated with azithromycin 1 g single dose orally and tetracycline/betamethasone eye ointment for one month. A complete resolution of symptoms was observed three months after aetiological treatment. This case highlights the need to include C. trachomatis infection in the differential diagnosis of acute or chronic follicular conjunctivitis among sexually active young individuals.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1406
[Js] Journal subset:IM
[St] Status:In-Process

  4 / 12881 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
PubMed Central Full text
Full text

[PMID]: 24368924
[Au] Autor:Galicia-Carreón J; Santacruz C; Ayala-Balboa J; Robles-Contreras A; Perez-Tapia SM; Garfias Y; Hong E; Jiménez-Martínez MC
[Ad] Address:Department of Pharmacobiology, CINVESTAV, IPN, P.O. Box 22106, 14330 Mexico, DF, Mexico....
[Ti] Title:An imbalance between frequency of CD4+CD25+FOXP3+ regulatory T cells and CCR4+ and CCR9+ circulating helper T cells is associated with active perennial allergic conjunctivitis.
[So] Source:Clin Dev Immunol;2013:919742, 2013.
[Is] ISSN:1740-2530
[Cp] Country of publication:Egypt
[La] Language:eng
[Ab] Abstract:Allergic conjunctivitis (AC) is one of the most common eye disorders in ophthalmology. In mice models, it has been suggested that control of allergic conjunctivitis is a delicate balance between Tregs and inflammatory migrating effector cells. Our aim was to evaluate the frequency of Tregs and the frequency of homing receptors expressing cells in peripheral blood mononuclear cells (PBMC) from patients with perennial allergic conjunctivitis (PAC). The analyses of phenotypic markers on CD4+ T cells and both soluble or intracellular cytokines were performed by flow cytometry. CD4+CD25+ cells were 15 times more frequent in PBMC from patients than HC; the vast majority of these CD4+CD25+ cells were FOXP3-, and most of CD4+ T cells were CCR4+ and CCR9+ cells. Upon allergen-stimulation, no significant changes were observed in frequency of Treg; however, an increased frequency of CD4+CCR4+CCR9+ cells, CD4+CD103+ cells and CD4+CD108+ cells with increased IL-5, IL-6, and IL-8 production was observed. These findings suggest an immune dysregulation in PAC, characterized by diminished frequency of Tregs and increased frequency of circulating activated CD4+ T cells; upon allergen-stimulation, these cells were expressing cell-surface molecules related to mucosa homing and were able to trigger an inflammatory microenvironment.
[Mh] MeSH terms primary: Conjunctivitis, Allergic/immunology
T-Lymphocytes, Helper-Inducer/immunology
T-Lymphocytes, Regulatory/immunology
[Mh] MeSH terms secundary: Adolescent
Antigens, Dermatophagoides/immunology
Child
Child, Preschool
Conjunctivitis, Allergic/metabolism
Cytokines/metabolism
Female
Forkhead Transcription Factors
Humans
Immunophenotyping
Interleukin-2 Receptor alpha Subunit/metabolism
Leukocytes, Mononuclear/immunology
Leukocytes, Mononuclear/metabolism
Lymphocyte Count
Male
Phenotype
Receptors, CCR/metabolism
Receptors, CCR4/metabolism
Receptors, Chemokine/metabolism
T-Lymphocytes, Helper-Inducer/metabolism
T-Lymphocytes, Regulatory/metabolism
[Pt] Publication type:JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T
[Nm] Name of substance:0 (Antigens, Dermatophagoides); 0 (CC chemokine receptor 9); 0 (Cytokines); 0 (FOXP3 protein, human); 0 (Forkhead Transcription Factors); 0 (Interleukin-2 Receptor alpha Subunit); 0 (Receptors, CCR); 0 (Receptors, CCR4); 0 (Receptors, Chemokine)
[Em] Entry month:1408
[Js] Journal subset:IM
[Da] Date of entry for processing:131225
[St] Status:MEDLINE
[do] DOI:10.1155/2013/919742

  5 / 12881 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
PubMed Central Full text
Full text

[PMID]: 23887766
[Au] Autor:Kheirkhah A; Nazari R; Safi H; Ghassemi H; Behrouz MJ; Raju VK
[Ad] Address:Farabi Eye Hospital, Eye Research Center, Tehran University of Medical Sciences, Tehran, Iran. Akheirkh@yahoo.com
[Ti] Title:Effects of intraoperative steroid injection on the outcome of pterygium surgery.
[So] Source:Eye (Lond);27(8):906-14, 2013 Aug.
[Is] ISSN:1476-5454
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:PURPOSE: To evaluate the effects of intraoperative triamcinolone injection on the outcome of pterygium surgery. METHODS: This prospective study included 54 eyes with primary nasal pterygia that underwent pterygium surgery with a bare-sclera technique and intraoperative mitomycin C application. Patients were randomized into two groups; the steroid group that received subconjunctival injection of 12 mg triamcinolone acetonide at the end of surgery, and the control group that did not receive such steroid injection. Main outcome measures included presence of conjunctival inflammation at 1 month postoperatively as well as recurrence of pterygium. RESULTS: Twelve-month follow-up was completed in 48 eyes (23 in the steroid group and 25 in the control group). At 1 month postoperatively, different grades of conjunctival inflammation were present in 11 (47.8%) of the steroid group and in 14 (56%) of the control group (P=0.39). For eyes with moderate or severe postoperative inflammation, subconjunctival triamcinolone was injected; these included 6 (26.1%) and 9 (36%) in the steroid and control groups, respectively (P=0.54). During follow-up, surgical area showed fine episcleral vessels without fibrous tissue in 1 (4.3%) of the steroid group and 3 (12.0%) of the control group (P=0.33), which all regressed after triamcinolone injection. Conjunctival recurrence of pterygium was seen in 2 (8.7%) of the steroid group and in 1 (4.0%) of the control group (P=0.47). No eye developed corneal recurrence in either group. CONCLUSIONS: In pterygium surgery with a bare-sclera technique and mitomycin C application, intraoperative triamcinolone injection did not significantly reduce postoperative conjunctival inflammation or pterygium recurrence.
[Mh] MeSH terms primary: Glucocorticoids/administration & dosage
Pterygium/surgery
Triamcinolone/administration & dosage
[Mh] MeSH terms secundary: Adult
Aged
Antibiotics, Antineoplastic/therapeutic use
Conjunctivitis/prevention & control
Female
Follow-Up Studies
Humans
Injections
Intraoperative Care/methods
Male
Middle Aged
Mitomycin/therapeutic use
Postoperative Complications
Prospective Studies
Pterygium/drug therapy
Recurrence
Sclera/surgery
Young Adult
[Pt] Publication type:JOURNAL ARTICLE; RANDOMIZED CONTROLLED TRIAL
[Nm] Name of substance:0 (Antibiotics, Antineoplastic); 0 (Glucocorticoids); 1ZK20VI6TY (Triamcinolone); 50SG953SK6 (Mitomycin)
[Em] Entry month:1402
[Cu] Class update date: 140803
[Lr] Last revision date:140803
[Js] Journal subset:IM
[Da] Date of entry for processing:130808
[St] Status:MEDLINE
[do] DOI:10.1038/eye.2013.142

  6 / 12881 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 23473088
[Au] Autor:González-López JJ; Morcillo-Laiz R; Muñoz-Negrete FJ
[Ad] Address:Servicio de Oftalmología, Hospital Universitario Ramón y Cajal, Madrid, Spain. juliojose.gonzalez@live.com
[Ti] Title:Adenoviral keratoconjunctivitis: an update.
[So] Source:Arch Soc Esp Oftalmol;88(3):108-15, 2013 Mar.
[Is] ISSN:1989-7286
[Cp] Country of publication:Spain
[La] Language:eng; spa
[Ab] Abstract:The objective of this review is to describe the clinical and epidemiological characteristics of adenoviral conjunctivitis, as well as to present a practical update on its diagnosis, treatment and prophylaxis. There are two well-defined adenoviral keratoconjunctivitis clinical syndromes: epidemic keratoconjunctivitis and pharyngoconjunctival fever, which are caused by different adenovirus serotypes. The exact incidence of adenoviral conjunctivitis is unknown. However, cases are more frequent during warmer months. Contagion is possible through direct contact or fomites and the virus is extremely resistant to different physical and chemical agents. The symptomatology of conjunctival infection is similar to any other conjunctivitis, with a higher incidence of pseudomembranes. In the cornea, adenoviral infection may lead to keratitis nummularis. Diagnosis is mainly clinical, but its etiology can be confirmed using cell cultures, polymerase chain reaction or immunochromatography. Multiple treatments have been tried for this disease, but none of them seem to be completely effective. Prevention is the most reliable way to control this contagious infection.
[Mh] MeSH terms primary: Adenoviridae Infections
Keratoconjunctivitis/virology
[Mh] MeSH terms secundary: Adenoviridae Infections/diagnosis
Adenoviridae Infections/therapy
Humans
Keratoconjunctivitis/diagnosis
Keratoconjunctivitis/therapy
[Pt] Publication type:JOURNAL ARTICLE; REVIEW
[Em] Entry month:1408
[Js] Journal subset:IM
[Da] Date of entry for processing:130311
[St] Status:MEDLINE

  7 / 12881 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
Full text

[PMID]: 25079463
[Au] Autor:Stagi S; Pucci N; di Grande L; de Libero C; Caputo R; Pantano S; Seminara S; de Martino M; Novembre E
[Ad] Address:Department of Health's Sciences, University of Florence,Florence, Italy....
[Ti] Title:Increased prevalence of growth hormone deficiency in patients with vernal keratoconjuntivitis; An interesting new association.
[So] Source:Hormones (Athens);13(3):382-8, 2014 Jul.
[Is] ISSN:1109-3099
[Cp] Country of publication:Greece
[La] Language:eng
[Ab] Abstract:INTRODUCTION: Vernal keratoconjunctivitis (VKC) is a chronic conjunctivitis that mainly affects children living in temperate areas. The notable difference between genders and VKC's resolution with puberty have persistently suggested a role of hormonal factors in VKC development. OBJECTIVE: To describe six cases of males with VKC and growth hormone deficiency (GHD) reported as a long-term follow-up during rhGH treatment. METHODS: Six consecutive male patients (median age at GHD diagnosis 9.7, range 7.9 to 13.1 years) with VKC, were recruited from July 2005 to July 2013 at the Paediatric Endocrinology Unit of Anna Meyer Children's Hospital in Florence, Italy. In these patients, anthropometric data were collected periodically. In three of these patients, data were collected to near-adult or adult height. RESULTS: Familial history was uneventful for all patients. The target height was normal, ranging from 0.65 standard deviation scores (SDS) to 2.01 SDS. The patients showed a normal birth-weight (from -1.21 to 1.35 SDS) and birth-length (from -0.93 to 1.21 SDS). At GHD diagnosis, all of the patients exhibited demonstrated important growth retardation (from -2.05 to -2.78 SDS). Plasmatic concentrations of IGF-1 and IGFBP-3 were low (from -1.85 to -3 SDS and from -1.81 to -2.76 SDS, respectively). GH stimulation tests showed classic GHD symptoms in all of the patients. Pubertal onset was normal. All of the patients treated with rhGH responded well to rhGH treatment. Adult height, evaluated in three patients, was in accordance with their target height. CONCLUSIONS: To our current knowledge, we have described for the first time six patients affected by VKC with GH deficiency, in some of whom we performed a long-term follow-up to adult height. Further studies will be needed to establish whether GHD may be a common feature of VKC patients. Nevertheless, it appears to be useful to carefully follow statural growth of VKC patients, while the possibility of a GH deficiency must to be taken into account in the presence of growth failure.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1408
[Js] Journal subset:IM
[St] Status:In-Data-Review
[do] DOI:10.14310/horm.2002.1499

  8 / 12881 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
PubMed Central Full text
Full text

[PMID]: 23815865
[Au] Autor:Eguchi H; Miyamoto T; Kuwahara T; Mitamura S; Mitamura Y
[Ti] Title:Infectious conjunctivitis caused by Pseudomonas aeruginosa isolated from a bathroom.
[So] Source:BMC Res Notes;6(1):245, 2013.
[Is] ISSN:1756-0500
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:BACKGROUND: The elucidation of the routes of transmission of a pathogen is crucial for the prevention of infectious diseases caused by bacteria that are not a resident in human tissue. The purpose of this report is to describe a case of suture-related conjunctivitis caused by Pseudomonas aeruginosa for which we identified the transmission route using pulsed-field gel electrophoresis (PFGE). CASE PRESENTATION: A 38-year-old man, who had undergone surgery for glaucoma 2 years ago previously, presented with redness, discomfort, and mucopurulent discharge in the right eye. A 9-0 silk suture had been left on the conjunctiva. A strain of P. aeruginosa was isolated from a culture obtained from the suture, and the patient was therefore diagnosed with suture-related conjunctivitis caused by P. aeruginosa. The conjunctivitis was cured by the application of an antimicrobial ophthalmic solution and removal of the suture. We used PFGE to survey of the indoor and outdoor environments around the patient's house and office in order to elucidate the route of transmission of the infection. Three strains of P. aeruginosa were isolated from the patient's indoor environment, and the isolate obtained from the patient's bathroom was identical to that from the suture. CONCLUSION: The case highlights the fact that an indoor environmental strain of P. aeruginosa can cause ocular infections.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1407
[Js] Journal subset:IM
[St] Status:In-Data-Review
[do] DOI:10.1186/1756-0500-6-245

  9 / 12881 MEDLINE  
              first record previous record next record last record
select
to print
Photocopy
PubMed Central Full text
Full text

[PMID]: 23725348
[Au] Autor:Murphy K; Gawchik S; Bernstein D; Andersen J; Pedersen MR
[Ti] Title:A phase 3 trial assessing the efficacy and safety of grass allergy immunotherapy tablet in subjects with grass pollen-induced allergic rhinitis with or without conjunctivitis, with or without asthma.
[So] Source:J Negat Results Biomed;12:10, 2013.
[Is] ISSN:1477-5751
[Cp] Country of publication:England
[La] Language:eng
[Ab] Abstract:BACKGROUND: Design and execution of immunotherapy trials for seasonal allergies may be complicated by numerous factors including variable allergy testing methods, pollen levels, and timing and intensity of other seasonal allergens. We evaluated grass allergy immunotherapy tablet (AIT) treatment in North American adults with grass pollen-induced allergic rhinitis with or without conjunctivitis (AR/C), with/without asthma. METHODS: Subjects age 18-65 with clinical history of grass pollen-induced AR/C, with/without asthma were randomized 1:1 to once-daily 2800 BAU Timothy grass AIT (oral lyophilisate, Phleum pratense, 75,000 SQ-T, containing approximately 15 µg of Phl p 5) or placebo. The AR/C symptom and medication scores were recorded daily. The primary end point was the average AR/C daily symptom score (DSS) during the entire grass pollen season (GPS). Ranked key secondary end points were Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) score, daily medication score (DMS), and percentage of well days, all over entire GPS. Safety was monitored through adverse event reporting. RESULTS: Efficacy analysis included 289 subjects. Over the entire GPS, mean DSS was 6% lower with AIT versus placebo (5.69 vs. 6.06), but this difference was not statistically significant (p = 0.3475) despite significantly higher immunological response in the grass AIT group. No significant between-group differences were seen for key secondary end points. In general, DSS was high before GPS began and no clear relationship between DSS and grass pollen counts was seen during GPS. In post hoc analysis of subjects with pre-seasonal DSS ≤3, mean DSS and DMS were both significantly lower with grass AIT versus placebo (27%; p = 0.0327 and 68%; p = 0.0060, respectively). In this subgroup a relationship between DSS and grass pollen counts was observed. Grass AIT was generally well tolerated, with no events of anaphylactic shock or respiratory compromise. CONCLUSIONS: In this trial, 2800 BAU grass AIT did not demonstrate significant symptom improvement versus placebo. Lack of relationship between pollen count and symptom score in the study population, and post hoc findings among subjects with low pre-seasonal symptoms, suggest that the symptoms reported in this study were not primarily reflective of the effects of grass pollen exposure. TRIAL REGISTRATION: NCT00421655.
[Pt] Publication type:JOURNAL ARTICLE
[Em] Entry month:1407
[Js] Journal subset:IM
[St] Status:In-Data-Review
[do] DOI:10.1186/1477-5751-12-10

  10 / 12881 MEDLINE  
              first record previous record
select
to print
Photocopy

[PMID]: 25051701
[Au] Autor:Gervazieva VB; Lysogora VA
[Ti] Title:[Evaluation of some immunological indexes in children with allergic diseases and obesity].
[So] Source:Zh Mikrobiol Epidemiol Immunobiol;(2):78-85, 2014 Mar-Apr.
[Is] ISSN:0372-9311
[Cp] Country of publication:Russia (Federation)
[La] Language:rus
[Ab] Abstract:AIM: Study some immunological indexes in children with allergic diseases depending on bodyweight and clinical manifestations of allergy. MATERIALS AND METHODS: A correlation analysis of relationship of indexes of natural resistance (phagocytosis, complement), immunoglobulin level and main lymphocyte populations with body weight in 214 children aged 12 - 17 years with various allergic diseases (rhinitis/ rhinoconjunctivitis, atopic dermatitis, bronchial asthma) was carried out. The children were divided into groups based on body mass index (BMI): 73 (34%) children with normal weight, 74 (35%) overweight and 67 (31%) obese. RESULTS: The analysis has shown that the frequency of detection of children with obesity is the highest for age 12 - 14 years. With the increase of age the number of obese children decreases (OR - 9.0; 95% CI: 1.56 - 51.87; p = 0.008 and OR - 0.27; 95% CI: 0.08 - 0.94; p = 0.04, respectively). An interrelation of BMI with clinical exacerbations of allergy was detected. Out of 166 patients with allergic diseases combined with bronchial asthma excessive weight was detected in 62 (37%), obesit--in 57 (34%) and normal weigh--in 47 (28%). In a group of 48 children with allergy without asthma excessive weight was noted in 12 (25%), obesit--in 10 (21%) and normal weigh--in 26 (54%) of patients. In children with bronchial asthma excessive weight occurs almost 3 times more frequently than in children with allergy and without asthma. Differences could not be detected in 3 groups of children when immune status indexes were compared, except total IgE and NK cell levels. Total IgE level was the highest in obese children (2.7 log), differed significantly from the level in obese (2.46 log) and normal weight (2.37 log, r = 0.32, p < 0.05) children. The relative content of NK cells in blood of obese children was significantly higher than in children withnoormal and excessive weight (r = 0.41). The analysis of significant correlation coefficient indexes detected correlative associations of some immunological indexes with BMI. In overweight children a negative relation between the level of complement and BMI (r = -0.61) and positive relation with phagocytosis index (r = 0.58) were detected. CONCLUSION: Obesity in children with allergic diseases is associated with an increase of conjugation of immunological indexes manifesting in an increase of number of natural killers (NK), phagocytosis indexes, increased total IgE level against the background of negative interrelation with the main populations of lymphocytes, that in general influences aggravation of allergopathology in the form of a higher frequency of detection of atopic bronchial asthma.
[Mh] MeSH terms primary: Asthma/immunology
Conjunctivitis/immunology
Dermatitis, Atopic/immunology
Obesity/immunology
Rhinitis/immunology
[Mh] MeSH terms secundary: Adolescent
Asthma/blood
Asthma/epidemiology
Asthma/pathology
Body Mass Index
Child
Comorbidity
Conjunctivitis/blood
Conjunctivitis/epidemiology
Conjunctivitis/pathology
Dermatitis, Atopic/blood
Dermatitis, Atopic/epidemiology
Dermatitis, Atopic/pathology
Female
Humans
Immunoglobulin E/blood
Killer Cells, Natural/immunology
Killer Cells, Natural/pathology
Lymphocyte Count
Male
Obesity/blood
Obesity/epidemiology
Obesity/pathology
Phagocytosis
Rhinitis/blood
Rhinitis/epidemiology
Rhinitis/pathology
Russia/epidemiology
[Pt] Publication type:ENGLISH ABSTRACT; JOURNAL ARTICLE
[Nm] Name of substance:37341-29-0 (Immunoglobulin E)
[Em] Entry month:1408
[Js] Journal subset:IM
[Da] Date of entry for processing:140723
[St] Status:MEDLINE


page 1 of 1289 go to page                         
   


Refine the search
  Database : MEDLINE Advanced form   

    Search in field  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information